Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 76 AL 90

Pharmacogenetics of anxiety and depression in Alzheimer's disease

Cacabelos R, Carril JC, Corzo L, Pego R, Cacabelos N, Alcaraz M, Muñiz A, Martínez-Iglesias O, Naidoo V.

Pharmacogenomics. 2023 Jan;24(1):27-57. doi: 10.2217/pgs-2022-0137. Epub 2023 Jan 11.

The interactions of amyloid β aggregates with phospholipid membranes and the implications for neurodegeneration

Budvytyte R, Valincius G.

Biochem Soc Trans. 2023 Feb 27;51(1):147-159. doi: 10.1042/BST20220434.

Impact of nanoparticles on amyloid β-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review

Chakraborty A, Mohapatra SS, Barik S, Roy I, Gupta B, Biswas A.

Biosci Rep. 2023 Feb 27;43(2):BSR20220324. doi: 10.1042/BSR20220324.

The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease

Valis M, Dlabkova A, Hort J, Angelucci F, Pejchal J, Kuca K, Pavelek Z, Karasova JZ, Novotny M.

Biomed Pharmacother. 2023 Mar;159:114223. doi: 10.1016/j.biopha.2023.114223. Epub 2023 Jan 9.

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

Castro CB, Dias CB, Hillebrandt H, Sohrabi HR, Chatterjee P, Shah TM, Fuller SJ, Garg ML, Martins RN.

Nutr Rev. 2023 Aug 10;81(9):1144-1162. doi: 10.1093/nutrit/nuac104.

Photobiomodulation for Alzheimer's disease: photoelectric coupling effect on attenuating Aβ neurotoxicity

Tian Z, Wang P, Huang K, Yu J, Zhang M, Liu Y, Zhao H, Zhu B, Huang X, Tong Z.

Lasers Med Sci. 2023 Jan 12;38(1):39. doi: 10.1007/s10103-022-03692-z.

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

Moore KBE, Hung TJ, Fortin JS.

Drug Discov Today. 2023 Mar;28(3):103487. doi: 10.1016/j.drudis.2023.103487. Epub 2023 Jan 9.

TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment

Ayyubova G.

Eur J Neurosci. 2023 Feb;57(4):718-733. doi: 10.1111/ejn.15914. Epub 2023 Jan 29.

Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

Abd-Nikfarjam B, Dolati-Somarin A, Baradaran Rahimi V, Askari VR.

Biofactors. 2023 May-Jun;49(3):560-583. doi: 10.1002/biof.1936. Epub 2023 Jan 13.

Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer's disease in aging women

Tecalco-Cruz AC, López-Canovas L, Azuara-Liceaga E.

Metab Brain Dis. 2023 Mar;38(3):783-793. doi: 10.1007/s11011-023-01161-2. Epub 2023 Jan 14.

Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer's disease

Punmiya A, Prabhu A.

Neurochem Int. 2023 Feb;163:105486. doi: 10.1016/j.neuint.2023.105486. Epub 2023 Jan 11.

Programmed Death of Microglia in Alzheimer's Disease: Autophagy, Ferroptosis, and Pyroptosis

Qiu Z, Zhang H, Xia M, Gu J, Guo K, Wang H, Miao C.

J Prev Alzheimers Dis. 2023;10(1):95-103. doi: 10.14283/jpad.2023.3.

Embryo Selection for a Carrier of an Early-Onset Alzheimer's Disease-Associated Mutation in the PSEN1 Gene

Valdés-Martínez OH, García-Luna SM, Oceguera-Palao LC, Villarreal-Pineda L, Sordia-Hernández LH, de la Fuente Cortez B, Morales-Martínez A.

J Prev Alzheimers Dis. 2023;10(1):144-147. doi: 10.14283/jpad.2023.4.

Exosomes: A missing link between chronic systemic inflammation and Alzheimer's disease?

Ozansoy M, Mikati H, Velioglu HA, Yulug B.

Biomed Pharmacother. 2023 Mar;159:114161. doi: 10.1016/j.biopha.2022.114161. Epub 2023 Jan 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias